Abstract
Strenuous physical activity alleviates the risk of elevated blood pressure (BP) presumably through a reduction in systemic vascular resistance (SVR). Using logistic multivariate regression models, we investigated whether moderate to vigorous physical activity (MVPA) was negatively associated with high SVR among adults with Type 2 Diabetes (T2DM). Additionally, we assessed associations between other cardiometabolic risk factors and SVR. SVR was assessed using thoracic electrical bioimpedance; high SVR was defined as ≥20% above normal. Time spent on MVPA was calculated using accelerometer data and age-specific cut points. In fasting blood samples, we measured plasma glucose and c-peptide and used the Homeostasis Model Assessment 2-Insulin Resistance (HOMA2-IR) to estimate Insulin resistance. Results are adjusted for age, sex, BP, body mass index (BMI), HOMA2-IR, medication, and smoking. We included 824 adults (mean age = 61.6 years) with recently diagnosed T2DM (interquartile range for diabetes duration = 4.9 years). 41% were females. Median MVPA was 10.7 min/day, and 50.5% had high SVR. Increments of 14.4 min/day in MVPA were independently associated with a lower risk of high SVR (OR = 0.69, [0.57;0.83]). Other risk determinants of high SVR were female sex (OR = 2.06, [1.49;2.86]), each increase in BMI of 6.16 kg/m2 (OR = 2.20, [1.76;2.73]), and HOMA2-IR of 1.79 (OR = 2.33, [1.09;4.96]). BMI had a notably greater impact on explained variability of SVR than MVPA when comparing the coefficient of determination (pseudo-R2, 35.0% vs. 7.9%). Although increased levels of MVPA are associated with a reduced risk of high SVR, BMI appears to have a more pronounced effect on SVR.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are not publicly available due to Danish data security regulations but are available from the corresponding author on reasonable request.
References
Rossier BC, Bochud M, Devuyst O. The hypertension pandemic: an evolutionary perspective. Physiology. 2017;32:112–25.
Julius S. Phenotypic changes in the transition from prehypertension to established hypertension. In: Berbari AE, Mancia G, editors. Disorders of blood pressure regulation: phenotypes, mechanisms, therapeutic options. Cham: Springer International Publishing; 2018. pp. 587–98.
Lu DY, Fang Q, Bibby D, Arora B, Schiller NB. Association of systemic vascular resistance analog and cardiovascular outcomes: The Heart and Soul Study. J Am Heart Assoc. 2022;11:e026016.
Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34:575–84.
Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. Type 2 diabetes mellitus and hypertension. Endocrinol Metab Clin North Am. 2014;43:103–22.
Rijal A, Nielsen EE, Adhikari TB, Dhakal S, Maagaard M, Piri R, et al. Effects of adding exercise to usual care in patients with either hypertension, type 2 diabetes or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis. Br J Sports Med. 2023;57:930–9.
Carey RM, Moran AE, Whelton PK. Treatment of hypertension. JAMA. 2022;328:1849.
Fagard RH. Exercise is good for your blood pressure: effects of endurance training and resistance training. Clin Exp Pharmacol Physiol. 2006;33:853–6.
McDonnell, Maki-Petaja BJ, Munnery KM, Yasmin M, Wilkinson IB, Cockcroft JR, et al. Habitual exercise and blood pressure: age dependency and underlying mechanisms. Am J Hypertens. 2013;26:334–41.
Ring M, Eriksson MJ, Fritz T, Nyberg G, Östenson CG, Krook A, et al. Influence of physical activity and gender on arterial function in type 2 diabetes, normal and impaired glucose tolerance. Diab Vasc Dis Res. 2015;12:315–24.
Loimaala A, Huikuri HV, Kööbi T, Rinne M, Nenonen A, Vuori I. Exercise training improves baroreflex sensitivity in type 2 diabetes. Diabetes. 2003;52:1837–42.
Sacre JW, Holland DJ, Jenkins C, Sharman JE. Augmentation index immediately after maximal exercise in patients with type 2 diabetes mellitus. Med Sci Sports Exerc. 2012;44:75–83.
Stidsen JV, Nielsen JS, Henriksen JE, Friborg SG, Thomsen RW, Olesen TB, et al. Protocol for the specialist supervised individualised multifactorial treatment of new clinically diagnosed type 2 diabetes in general practice (IDA): a prospective controlled multicentre open-label intervention study. BMJ Open. 2017;7:e017493.
Nielsen JS, Thomsen RW, Steffensen C, Christiansen JS. The Danish centre for strategic research in type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment system. Clin Epidemiol. 2012;4:27–36.
Faini A, Omboni S, Tifrea M, Bubenek S, Lazar O, Parati G. Cardiac index assessment: validation of a new non-invasive very low current thoracic bioimpedance device by thermodilution. Blood Press. 2014;23:102–8.
Talvik A, Rebora P, Heinpalu-Kuum M, Salerno S, Miszkowska-Nagórna E, Liu X, et al. Non-invasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients: effects on home blood pressure in the BEAUTY study. Blood Press. 2018;27:368–75.
Brønd JC, Aadland E, Andersen LB, Resaland GK, Andersen SA, Arvidsson D. The ActiGraph counts processing and the assessment of vigorous activity. Clin Physiol Funct Imaging. 2019;39:276–83.
Domazet SL, Tarp J, Thomsen RW, Højlund K, Stidsen JV, Brønd JC, et al. Accelerometer-derived physical activity and sedentary behaviors in individuals with newly diagnosed type 2 diabetes: a cross-sectional study from the Danish nationwide DD2 cohort. Front Sports Act Living. 2022;4:1089579.
Ahrensberg H, Toftager M, Nørgaard S, Petersen CB. Fysisk aktivitet for voksne (18-64 år): Viden om sundhed og forebyggelse. Sundhedsstyrelsen, 2023. 79 p.
DeMers D, Wachs D. Physiology, Mean Arterial Pressure. [Updated 2023 Apr 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538226/.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604.
Hill NR, Levy JC, Matthews DR. Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2. Diabetes Care. 2013;36:2324–30.
Kähönen E, Aatola H, Lehtimäki T, Haarala A, Sipilä K, Juonala M, et al. Influence of early life risk factors and lifestyle on systemic vascular resistance in later adulthood: the cardiovascular risk in young Finns study. Blood Press. 2021;30:367–75.
Green DJ, Smith KJ. Effects of exercise on vascular function, structure, and health in humans. Cold Spring Harb Perspect Med. 2018;8:a029819.
MacIntosh BR, Murias JM, Keir DA, Weir JM. What is moderate to vigorous exercise intensity? Front Physiol. 2021;12:682233.
Bogaert YE, Linas S. The role of obesity in the pathogenesis of hypertension. Nat Clin Pract Nephrol. 2009;5:101–11.
Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315.
Di Pino A, DeFronzo RA. Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents. Endocr Rev. 2019;40:1447–67.
Thorp AA, Schlaich MP. Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J Diabetes Res. 2015;2015:341583.
Chen J, Wang X, Dong B, Liu C, Zhao J, Dong Y, et al. Cardiac function and exercise capacity in patients with metabolic syndrome: a cross-sectional study. Front Cardiovasc Med. 2022;9:974802.
Coutinho T, Borlaug BA, Pellikka PA, Turner ST, Kullo IJ. Sex differences in arterial stiffness and ventricular-arterial interactions. J Am Coll Cardiol. 2013;61:96–103.
Krzesiński P, Stańczyk A, Gielerak G, Uziębło-Życzkowska B, Kurpaska M, Piotrowicz K, et al. Sex determines cardiovascular hemodynamics in hypertension. J Hum Hypertens. 2015;29:610–7.
Raj A, Chakole S, Agrawal S, Gupta A, Khekade H, Prasad R, et al. The impact of menopause on cardiovascular aging: a comprehensive review of androgen influences. Cureus. 2023;15:e43569.
Joyner MJ, Wallin BG, Charkoudian N. Sex differences and blood pressure regulation in humans. Exp Physiol. 2016;101:349–55.
Arvidsson D, Fridolfsson J, Börjesson M. Measurement of physical activity in clinical practice using accelerometers. J Intern Med. 2019;286:137–53.
Acknowledgements
We would like to extend our sincere gratitude to the many patients who participated in the IDA study. Their contributions have made this research project possible.
Funding
The study was supported by the Danish Agency for Science (grant nos. 09-067009 and 09-075724), the Region of Southern Denmark, the Region of Zealand, the Augustinus Foundation, the Herta Christensen Foundation, the Novo Nordisk Foundation and the University of Southern Denmark. The Biobank was supported by an unrestricted donation from Novo Nordisk A/S. Project partners are listed on the project website (https://dd2.dk/).
Author information
Authors and Affiliations
Contributions
Conceptualization of IDA study: JVS, TBO, JSN and Henning Beck-Nielsen Conceptualization of current study: SBN, TBO and JVS. Data curation: JVS. Formal analysis: SBN, TBO and JVS. Investigation: TBO and JVS. Methodology: SBN, TBO, JVS, SLD, SFK, JSN and MHO. Supervision: TBO and JVS. Validation: TBO, JVS, SLD, SFK, JSN and MHO. Writing – original draft preparation: SBN, TBO and JVS. Writing – review & editing: TBO, JVS, SLD, SFK, JSN and MHO. All authors provided critical comment.
Corresponding author
Ethics declarations
Competing interests
MHO has in relation to lectures received honorary from Novo Nordisk A/S, Teva A/S, and AstraZeneca A/S.
Ethical approval
The IDA study was approved by the Regional Committee on Medical Health Ethics (Region of Southern Denmark S-20120186), the Danish Data Protection Agency and Medicines Authority (journal no. 2012120204) and was conducted in concordance with the Helsinki declaration II.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nguyen, S.B., Olesen, T.B., Domazet, S.L. et al. Impact of moderate to vigorous physical activity on systemic vascular resistance in Danish adults with recently diagnosed type 2 diabetes: a cross-sectional study. J Hum Hypertens 39, 701–708 (2025). https://doi.org/10.1038/s41371-025-01049-x
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41371-025-01049-x


